• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT HBSAG QUALITATIVE II CONFIRMATORY; HBSAG CONFIRMATORY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT HBSAG QUALITATIVE II CONFIRMATORY; HBSAG CONFIRMATORY Back to Search Results
Catalog Number 02G23-25
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/28/2020
Event Type  malfunction  
Manufacturer Narrative
Patient information: no patient specific information was provided.This report is being filed on an international product, architect hbsag qualitative ii confirmatory, list 2g23, that has a similar product distributed in the us, hbsag confirmatory, list number 4p54.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer obtained a (b)(6) architect hbsag qualitative ii confirmatory result.Sample id (b)(6) generated (b)(6) results on roche (b)(6).The sample was tested neat on the architect hbsag qualitative ii confirmatory assay and generated an not confirmed result with c1 (b)(6) and c2 (b)(6).The sample was repeated neat generating similar not confirmed results of c1 (b)(6) and (b)(6).The sample was diluted 1:500 and generated confirmed (b)(6) result with c1 (b)(6) and %neutralization of 99.97%.No impact to patient management was reported.
 
Manufacturer Narrative
Correction to section d2: product code was change from ksj to lom.Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, in-house testing, review of manufacturing documents and a review of labeling.Return testing was not completed as returns were not available.The customer's instrument logs were reviewed, which confirmed the information provided by the customer.Review of complaint trending reports did not identify any trends for the architect hbsag qualitative ii confirmatory assay.Normal complaint activity was identified for reagent lot 04338fn00.Clinical sensitivity testing was performed using a retained kit of the compaint lot.All specifications were met indicating that the lot is performing acceptably.Manufacturing documentation for the reagent lot was reviewed and did not identify any issues.Labeling was reviewed and sufficiently addresses the customer's issue.No systemic issue or deficiency of the architect hbsag qualitative ii confirmatory assay was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HBSAG QUALITATIVE II CONFIRMATORY
Type of Device
HBSAG CONFIRMATORY
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
diagnostics division
sligo NA
EI  NA
MDR Report Key9825961
MDR Text Key225593991
Report Number3008344661-2020-00026
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 04/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/07/2020
Device Catalogue Number02G23-25
Device Lot Number04338FN00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/28/2020
Initial Date FDA Received03/12/2020
Supplement Dates Manufacturer Received04/20/2020
Supplement Dates FDA Received04/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR, LIST 03M74-02,; ARCHITECT I2000SR, LIST 03M74-02,; SERIAL (B)(6) ; SERIAL (B)(6)
-
-